Leukodystrophy is a group of congenital neurodegenerative disorders in which insufficient synthesis of certain enzymes leads to the accumulation of metabolites in brain tissues, causing the breakdown of myelin. Given the severe course and rarity of this disease, its successful diagnosis and therapy require high qualifications and extensive experience from specialists. Treatment of leukodystrophy in Israel follows a program developed based on data obtained from the patient's examination, and in most cases, it allows for alleviating painful symptoms, prolonging the patient's life, and improving its quality.
Early diagnosis is necessary for the prompt initiation of therapy, which improves prognosis and allows for the prevention of severe disorders. The excellent material and technical base of Israeli clinics, equipped with the latest high-precision diagnostic equipment, allows for a complete examination of the patient within just a few days, using high-precision instrumental and laboratory methods. This helps establish the causes of the emerging disorders, describe the characteristic signs and features of the pathology, and assess the overall condition of the patient. Feedback from parents of patients who have undergone treatment in Israel emphasizes both the effectiveness and reasonable cost of therapy, as well as the comfortable conditions and friendliness of the medical staff.
Treatment Methods for the Disease
In leukodystrophy, the white matter of the brain is affected, which is where the name of the disease comes from. There are approximately 60 varieties of the pathology, differing in the type of genetic disorders and the age at which the first clinical symptoms appear in the patient. The main and most well-known types of the disease are metachromatic, globoid-cell, and sudanophilic leukodystrophies, with each variety further divided into several forms depending on the age of manifestation.
The causes of leukodystrophy lie in genetically determined disturbances in the synthesis of certain enzymes. Defective enzyme production leads to lipid metabolism disorders and the accumulation of metabolites in certain organs, primarily the kidneys and liver. At the cellular level, metabolic disturbances lead to the destruction of myelin, which is part of the conducting nerve pathways, and the death of neurons, which are subsequently replaced by glial tissue.
Typically, the symptoms of the disease manifest in the first months of a child's life. At birth, the baby appears healthy, with no characteristic signs or disorders. After the onset of neurological symptoms, they steadily progress, primarily manifesting as a sharp deterioration in vision and hearing, ataxia, the development of epileptiform seizures, spastic paresis, behavioral changes, and delays in mental development up to oligophrenia. When diagnosing leukodystrophy, the prognosis is uncertain; the success of treatment aimed at maximizing the slowing of disease progression and improving the patient's quality of life depends on the stage at which it was initiated.
As with other diseases caused by genetic disorders, there are currently no methods developed that allow for the complete cessation of disease progression and the restoration of lost functions. However, the progressive treatment methods used in Israel allow for the normalization of the patient's condition and the maximum stabilization of brain function.
Medication Treatment
The course of drug therapy includes medications aimed at alleviating symptoms, normalizing metabolic processes, and preventing the development of epileptiform seizures. Patients are prescribed anticonvulsants and dehydrating agents, hormonal medications, folic acid antagonists, cytostatic drugs, and vitamin-mineral complexes. To replenish missing elements, erythrocyte mass and blood plasma transfusions are performed, and tissue extracts are administered.
Bone Marrow Transplantation
This is essentially the only effective method for treating leukodystrophy. When transplanting donor bone marrow or umbilical cord blood (allogeneic transplantation), the level of the deficient protein is normalized, metabolism improves, resulting in a noticeable increase in the quality and duration of the patient's life. However, it should be noted that the procedure has several serious limitations.
Transplantation should be performed as early as possible, before the patient develops pronounced neurological disorders. This is because, no matter how successful the transplantation is performed, it does not allow for the correction of existing disorders, only leading to a slowing of their progression. Considering the rapid progression of some forms of leukodystrophy and the severe condition of the patient, which can lead to disability or death, it is not possible to avoid these outcomes even after transplantation. This is explained by the fact that after the procedure, 1-2 years must pass for the donor cells to restore the level of myelin. During this time, the disease can significantly progress, so the maximum effect of transplantation is achieved when it is performed before the onset of clinical symptoms.
In the case of allogeneic transplantation, there is always a risk of rejection of the transplanted material, the possibility of developing a "graft versus host" reaction, and infectious complications.
If bone marrow transplantation is contraindicated for any reason, palliative treatment is prescribed, aimed at possibly alleviating symptoms.
Send your records — an Ichilov physician will reply within 1–2 days, free of charge.
Diagnostic Methods for the Pathology
Establishing the correct diagnosis requires a multidisciplinary approach — the involvement of not only the treating physician but also a number of specialized specialists (pediatrician, neurologist, ophthalmologist, and others). In Israel, a comprehensive examination of the patient using high-precision instrumental and laboratory techniques takes about three days.
Upon arrival in the country and admission to the clinic, the patient is directed to a primary consultation with a leading neurologist. During the appointment, the doctor carefully studies the medical history (the first signs of the disease and the time they appeared, the sequence of their occurrence, nature, and severity), and inquires about the presence of similar pathologies in close relatives. After conducting a superficial examination, a list of necessary examinations is compiled, and referrals to other specialists are issued.
On the following day, the patient undergoes the prescribed diagnostic procedures:
- analysis of cerebrospinal fluid (CSF) — a necessary amount of CSF is obtained through a puncture, after which it is sent to the laboratory for detailed analysis. During the study, the transparency and color of the cerebrospinal fluid are assessed, which should normally be clear and colorless, the number and types of cells, and the levels of chloride salts and glucose are determined. A significant increase in protein content, caused by the destruction of brain cells, is characteristic of leukodystrophy.
- biochemical tests — the content of enzymes and accumulated metabolites is determined using specific techniques.
- neurosonography.
- echoencephalography.
- computed tomography (CT) and magnetic resonance imaging (MRI) of the brain — images clearly visualize areas of demyelination, and MRI can show them even before the appearance of clinical symptoms.
- molecular genetic testing.
- prenatal diagnosis.
The results are submitted for review by a medical board consisting of a neurologist and specialized specialists. After studying the obtained data, the doctors establish a diagnosis and develop a treatment plan.
How Much Does Treatment of the Disease Cost
The cost of treatment is among the most pressing questions. Undergoing a therapeutic course in an Israeli clinic allows the patient to save approximately 30% of the amount required in Western European countries, and up to 50% of the cost of similar services in the USA.
Advantages of Treatment in Israel
- Doctors with a high level of qualification and extensive experience.
- Medical centers equipped with modern medical equipment.
- Fast, high-precision diagnostics.
- Use of progressive treatment methods.
- Affordable prices.
By contacting an Israeli clinic, you can significantly improve the life of a patient even with such a severe disease. The main thing is not to delay and start treatment as soon as possible.